Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway

Background: Ibrutinib could increase the risk of atrial fibrillation (AF) in chronic lymphocytic leukemia (CLL) patients. However, the precise mechanism underlying ibrutinib-induced AF remains incompletely elucidated. Methods: We investigated the proportion of ibrutinib-treated CLL patients with new...

Full description

Bibliographic Details
Published in:Frontiers in Bioscience-Landmark
Main Authors: Huiyuan Qin, Bingyu Zheng, Zhiqiao Lin, Yumeng Ji, Cheng Wang, Huayuan Zhu, Chang Cui, Zidun Wang, Minglong Chen
Format: Article
Language:English
Published: IMR Press 2024-05-01
Subjects:
Online Access:https://www.imrpress.com/journal/FBL/29/5/10.31083/j.fbl2905201